|
Volumn 381, Issue 6581, 1996, Pages 434-438
|
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD28 ANTIGEN;
CD40 ANTIGEN;
INTERLEUKIN 2;
ALLOGRAFT;
ALLOIMMUNITY;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
B LYMPHOCYTE ACTIVATION;
CONTROLLED STUDY;
ENDOTHELIUM CELL;
GRAFT REJECTION;
HEART TRANSPLANTATION;
LIGAND BINDING;
MACROPHAGE;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
SKIN ALLOGRAFT;
T LYMPHOCYTE ACTIVATION;
ANIMALS;
ANTIGENS, CD;
ANTIGENS, CD28;
ANTIGENS, CD40;
ANTIGENS, DIFFERENTIATION;
CELLS, CULTURED;
CYTOKINES;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART TRANSPLANTATION;
IMMUNOCONJUGATES;
LYMPHOCYTE ACTIVATION;
MALE;
MICE;
MICE, INBRED C3H;
MICE, INBRED C57BL;
MICE, INBRED DBA;
MICE, TRANSGENIC;
RECEPTORS, ANTIGEN, T-CELL;
SKIN TRANSPLANTATION;
T-LYMPHOCYTES;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 15844404353
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/381434a0 Document Type: Article |
Times cited : (1300)
|
References (29)
|